BIT's 14th Annual Congress of International Drug Discovery Science & Technology
Past Conference Report of IDDST- 2016


BIT's 14th Annual Congress of International Drug Discovery Science and Technology-2016 (IDDST- 2016), held in Nanjing International Youth Conference Center in Nov. 16-19, and achieved a consummation. The theme of this conference is “Olympic Campaign of Drug Innovation". Over 500 honored guests presented at the ceremony and plenary forum, among them are Dr. Arieh Warshel, Distinguished Professor, University of Southern California, Nobel Prize laureate in Chemistry, 2013; Dr. Ming-Qiang Zhang, Vice President of Research & General Manager, Amgen BioPharmaceutical R&D (Shanghai) Co., Ltd.; Dr. Kurt Herrenknecht, Founder & Managing Director, SciArcum Biotech Consulting; Yong Qian, Chairman, BioMedicure Group; Dr. Mingde Xia, Senior Director, Johnson & Johnson Innovation Asia-Pacific; Dr. Han-Koo Lee, Honorary Chairman, Daehwa Pharmaceuticals Co. Ltd. and other brilliant speakers.

This annual conference brought together 800 specialists from 40 countries and areas, which was devoted to the leading issues and popular topics and provide up-to-date information to all over the world.

This annual congress comprised 7 Parts and 23 sessions following the ceremony, including “Innovative “Drug Discovery Technology"; "Emerging Novel Drug Targets"; “Biomarkers and Personalized Medicine"; “New Biotherapy Discovery"; "Practice and Drug Innovation"; "Drug Discovery at the Cell Biology Level"; "Clinical Trials, Drug Administrative Approval, and Market Development"…etc.

Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing IDDST-2017 which would be better and more successful than IDDST-2016. All member of IDDST-2016 committee feel grateful for all participants’ contribution to our conference. We are looking forward to meeting you again in 2017.

About IDDST-2016

The 14th Annual Congress of International Drug Discovery Science & Technology - 2016 (IDDST-2016) will be held during November 16-19, 2016, at Nanjing, China. With 7 Supporting Concurrent Conferences in Medicinal Chemistry, Drug Delivery, Cancer Immunotherapy, Regenerative Medicine and Stem Cells, Microbes and Modern Chinese Medicine, as well as Variety Social Events, the IDDST-2016 will attract 2000+ Participants from 80+ Countries with 500+ Poster and Exhibition Presentations to join in the grand festival!

IDDST-2016 as the Main Conference of the Celebration Event will organize 100+ Parallel Sessions as well as Keynote Forum, and will approach 500+ Oral Presentations and 1000+ Participants. You can enjoy other 7 concurrent conferences Free with Only One Registration Pass of IDDST!

Nobel Laureates-2016
Dr. Arieh Warshel,
Distinguished Professor, University of Southern California, USA

Nobel Prize laureate in Chemistry, 2013
Dr. Dan Shechtman,
Professor, Israel Institute of Technology, Israel

Nobel Prize laureate in Chemistry, 2011
Dr. Aaron Ciechanover,
Distinguished Research Professor, Technion – Israel Institute of Technology , Israel

Nobel Prize laureate in Chemistry, 2004
Renowned Speakers of IDDST-2016 Dr. Arieh Warshel, Distinguished Professor, University of Southern California, USA Dr. Ming-Qiang Zhang,Vice President of Research & Development, General Manager, Amgen BioPharmaceutical R&D (Shanghai) Co., Ltd., China Dr. Kurt Herrenknecht, Founder & Managing Director, SciArcum Biotech Consulting, Germany Dr. Mingde Xia, Senior Director, Johnson & Johnson Innovation Asia-Pacific, USA Dr. Yong Qian, President & CEO,  BioMedicure LLC., USA and China Dr. Greg Friberg, Global Product General Manager, Amgen Inc., USA Dr. Wensheng Yu, Associate Principal Scientist, Rahway Discovery Chemistry, Merck Research Laboratories, USA Dr. Ye Che, Senior Principal Scientist, Pfizer, USA Dr. Anka G. Ehrhardt, Director Clinical Cytometry, Bristol-Myers Squibb Co., USA Dr. David Madge, Project Director, WuXi AppTec, UK Dr. Andreas Nechansky, Vice President of Research & Analytical Operations, JHL Biotech, Taiwan Dr. Francois Sautel, Open Innovation Leader, Institut de Recherche Pierre Fabre, France Dr. Jeffrey T. Apter, President, Global Clinical Trials, LLC, USA Dr. Bruce A. Donzanti, Senior Group Director, Genentech, Inc., USA Dr. Robert Scoffin, CEO, Re-Pharm Ltd., UK Dr. Cha-Mei Tang, President and CEO, Creatv MicroTech, Inc., USA Dr. Tsuneo Yano, Invited Professor & Chief Scientific Manager, Osaka University Graduate School of Science & Sumitomo Heavy Industries, Ltd., Japan Dr. Zheng Jim Wang, CTO, R&D General Manager, Advance Medical Systems Limited, China Dr. Michael N. Liebman, Managing Director, IPQ Analytics, LLC, USA Dr. Peter Schiemann, Managing Partner, Widler Schiemann Ltd., Switzerland Dr. Jenny Lin, Chief Operating Officer, CMIC, Inc., USA Dr. Alberto Pascual-Montano, Sr. Analytics Solution Architect, PerkinElmer, Inc., Spain Dr. Zhuohan Hu, President & CEO, Research Institute for Liver Diseases (Shanghai) Co., Ltd.; Professor, School of Pharmacy, Fudan University, China Dr. Dongliang Ge,President, BioSciKin Co., Ltd, China Dr. Le Sun, President & CEO, AbMax Biotechnology Co., China Dr. Ruo-Pan Huang, Founder & CEO, RayBiotech, Inc., China Dr. Raymond Yang, Senior Solutions Consultant, Oracle Health Sciences Global Business Unit, China Dr. Ziding Feng, Professor, The University of Texas, MD Anderson Cancer Center, USA Dr. Weiqiang (John) Zhao, Medical Director of Polaris Molecular Laboratory, The Ohio State University Wexner Medical Center, USA Dr. Xiaodong Liu, Vice President of School of Pharmacy, China Pharmaceutical University, China Dr. Mohammad Newaz, Professor and Chair of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, USA Dr. David C. Warhurst, Emeritus Professor of Protozoan Chemotherapy, London School of Hygiene and Tropical Medicine, UK Dr. Walter E.Muller, Professor, Goethe University Frankfurt, Germany Dr. Daijie Chen, Vice President, Shanghai Institute of Pharmaceutical Industry, China Dr. Laurent Desaubry, Research Director, CNRS-University of Strasbourg, France Dr. Ling Peng, Research Director, Centre Interdisciplinaire de Nanoscience de Marseille, Aix-Marseille University, CNRS, France Dr. Georgia Z. Chen, Professor, Emory University, USA Dr. Limin Chen, Professor, University of Toronto and Chinese Academy of Medical Sciences, Canada Dr. Christopher R. Triggle, Professor, Weill Cornell Medical College in Qatar, Canada Dr. Noah Isakov, Professor, Ben Gurion University of the Negev, Israel Dr. Guang Zhu, Professor, Hong Kong University of Science and Technology, Hong Kong, China Dr. Jianxin Bao, Director of the Translational Research Center, Northeast Ohio Medical University, USA Dr. Meihua R. Feng, Professor & Associate Research Scientist, University of Michigan, USA Dr. Robert A. Freeman, Professor and Vice Chair of Research, University of Maryland Eastern Shore School of Pharmacy,  USA Dr. Tapan K. Bera, Associate Scientist, National Cancer Institute, USA Dr. Francis S. Markland, Professor, Keck School of Medicine of the University of Southern California, USA Dr. Giovanni Dondi Dall’Orologio, Professor and Director, University of Bologna, Italy Dr. David A. Jans, Professor, Monash University, Australia Dr. Michael E. Mangelson, Intellectual Property Attaché, U. S. Patent and Trademark Office, U. S. Consulate General Shanghai, China Dr. Sabrina Molinaro, Head, Epidemiology and Health Research, National Research Council of Italy (Pisa), Italy Dr. Chia-Wei Tsai, Branch Chief, U.S. Department of Health and Human Services, USA Dr. Josef Jampilek, Associate Professor, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic Dr. Roumen Milev, Head, Department of Psychiatry, Queen’s University, Canada Dr. Qingwen Zhang, Professor, Shanghai Institute of Pharmaceutical Industry, China Dr. Chung-Hsin Wu, Professor, National Taiwan Normal University, Taiwan Dr. Wen G. Chen, Program Director, Division of Extramural Research, National Center for Complementary and Integrative Health (NCCIH), USA Dr. Stanislav Pavelka, Associate Professor, Masaryk University, Czech Republic
News Release

Enjoy special discount of Early Bird Rate!
Speaking Proposals Accepted Now!
Submit the Abstract Right Now!

Hosting Organization

Information Research Center of International Talent, SAFEA

Jiangsu Pharmaceutical Association

Operating Organization

BIT Group Global Ltd.
Foreign Experts Databank of SAFEA-Dalian Branch

Official Travel Agency
Media Partners
BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2015-2016 BIT Group Global Ltd.